Cilingir, B. Et Al. 2021. Can B-Type Natriuretic Peptide (BNP) Levels Serve as an Early Predictor of Clinical Severity in Patients with COVID-19 Pneumonia?. CLINICAL LABORATORY , vol.68, no.1 , 207-213.

Cilingir, B., Aşkar, S., Meral, A., & Aşkar, M., (2021). Can B-Type Natriuretic Peptide (BNP) Levels Serve as an Early Predictor of Clinical Severity in Patients with COVID-19 Pneumonia?. CLINICAL LABORATORY , vol.68, no.1, 207-213.

Cilingir, Buket Et Al. "Can B-Type Natriuretic Peptide (BNP) Levels Serve as an Early Predictor of Clinical Severity in Patients with COVID-19 Pneumonia?," CLINICAL LABORATORY , vol.68, no.1, 207-213, 2021

Cilingir, Buket Et Al. "Can B-Type Natriuretic Peptide (BNP) Levels Serve as an Early Predictor of Clinical Severity in Patients with COVID-19 Pneumonia?." CLINICAL LABORATORY , vol.68, no.1, pp.207-213, 2021

Cilingir, B. Et Al. (2021) . "Can B-Type Natriuretic Peptide (BNP) Levels Serve as an Early Predictor of Clinical Severity in Patients with COVID-19 Pneumonia?." CLINICAL LABORATORY , vol.68, no.1, pp.207-213.

@article{article, author={Buket Mermit Et Al. }, title={Can B-Type Natriuretic Peptide (BNP) Levels Serve as an Early Predictor of Clinical Severity in Patients with COVID-19 Pneumonia?}, journal={CLINICAL LABORATORY}, year=2021, pages={207-213} }